PTGS2 and cancer: Even though in 2002, the link between COX-2 and CRC was proposed, highlighting the enzyme’s importance in cancer biology [266] and many studies have demonstrated decrease in CRC development by inhibiting the COX enzymes (both or specifically COX-2) [267], the risk of their numerous side effects is still too high.